Form 4 for RGNX REGENXBIO Inc.
Accepted 2024-08-05 00:00:00 ET · period of report 2024-08-01 · accession 0001562180-24-006014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-08-05 | 2024-08-01 | RGNX | Simpson Curran | CEO, Dir | S - Sale | $15.00 | -100 | 170.0K | -0.1% | -$1,500 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-01 | S | D | 100 | $15.00 | 170,037 | D | — | — |